News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) Judge Certifies Class Action Over Celebrex, Bextra


3/30/2012 7:24:32 AM

Pfizer Inc. (PFE) failed to block class- action status for investors who sued the world’s biggest drugmaker over claims it misled them about the prospects of two chronic pain-relief drugs, Celebrex and Bextra. U.S. District Judge Laura Taylor Swain in New York, who is presiding over a series of investor suits filed in 2004, yesterday ruled that the main class of plaintiffs will be those who purchased stock from Oct. 31, 2000, to Oct. 19, 2005. The stockholders claimed New York-based Pfizer and its top officers deliberately hid or misrepresented the results of studies that suggested the drugs may have adverse cardiovascular effects.

Read at Bloomberg
Read at Michigan Live


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES